Guardant Health

Guardant Health is a premier precision oncology company dedicated to conquering cancer through blood-based liquid biopsy testing. The enterprise manufactures the Guardant360 comprehensive genomic profiling assay for therapy selection in advanced cancer patients alongside Shield, an FDA-approved blood test for early colorectal cancer screening. By detecting circulating tumor DNA in bloodstream samples, Guardant Health guides personalized cancer care and recurrence monitoring.